Immediate Impact
1 by Nobel laureates 9 from Science/Nature 60 standout
Citing Papers
IL-10 constrains sphingolipid metabolism to limit inflammation
2024 StandoutNature
Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
Works of Harry Dedman being referenced
Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P 1 ) and receptor‐5 (S1P 5 ) agonist with autoimmune disease‐modifying activity
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Harry Dedman | 189 | 64 | 93 | 77 | 7 | 338 | |
| Lone Frier Bovin | 169 | 124 | 48 | 117 | 11 | 370 | |
| Florian Nagl | 118 | 102 | 102 | 51 | 6 | 332 | |
| M Park | 218 | 127 | 76 | 36 | 6 | 397 | |
| Soon H. Kim | 192 | 52 | 56 | 79 | 9 | 354 | |
| Guoxun Liu | 140 | 89 | 115 | 67 | 7 | 318 | |
| Titus Sparna | 201 | 43 | 43 | 80 | 8 | 410 | |
| Katrina L. Scarff | 146 | 39 | 104 | 63 | 9 | 306 | |
| Ernst-Otto Riecken | 157 | 149 | 53 | 58 | 7 | 355 | |
| Hannah J. Whiteman | 247 | 151 | 39 | 89 | 7 | 405 | |
| Ashley M. Mahler | 109 | 26 | 34 | 142 | 8 | 374 |
All Works
Loading papers...